Literature DB >> 23448721

The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study.

Nina Hallowell1, Kathryn Alsop, Margaret Gleeson, Ashley Crook, Loren Plunkett, David Bowtell, Gillian Mitchell, Mary-Anne Young.   

Abstract

PURPOSE: The generation of clinically significant genetic data during research studies raises a number of ethical issues about the feedback of this information to research participants. Little is known about research participants' experiences of this practice.
METHODS: This qualitative interview study investigated research participants' (n = 10) or their nominated next of kin's (relatives) (n = 15) experiences of receiving BRCA1 and BRCA2 genetic test information following participation in the Australian Ovarian Cancer Study.
RESULTS: Interviewees had mixed responses to receiving feedback. The participants of the Australian Ovarian Cancer Study were more positive about receiving feedback, acknowledging that the genetic information may be useful for their kin. Relatives frequently described themselves as initially distressed at receiving feedback, particularly those who were unaware of the participation of their mothers in the Australian Ovarian Cancer Study. The participants of the Australian Ovarian Cancer Study and their relatives expressed an intention to disseminate the information to relatives following confirmation of the result.
CONCLUSION: We suggest that research participants be encouraged to discuss their participation with family members from the outset. We also outline a number of different strategies for providing feedback to research participants and their next of kin that may lessen the immediate negative impact of receiving feedback of research results.

Entities:  

Mesh:

Year:  2013        PMID: 23448721     DOI: 10.1038/gim.2012.154

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  12 in total

1.  Attitudes Toward Return of Genetic Research Results to Relatives, Including After Death: Comparison of Cancer Probands, Blood Relatives, and Spouse/Partners.

Authors:  Carmen Radecki Breitkopf; Susan M Wolf; Kari G Chaffee; Marguerite E Robinson; Noralane M Lindor; Deborah R Gordon; Barbara A Koenig; Gloria M Petersen
Journal:  J Empir Res Hum Res Ethics       Date:  2018-04-27       Impact factor: 1.742

2.  Timing and context: important considerations in the return of genetic results to research participants.

Authors:  Kate A McBride; Nina Hallowell; Martin H N Tattersall; Judy Kirk; Mandy L Ballinger; David M Thomas; Gillian Mitchell; Mary-Anne Young
Journal:  J Community Genet       Date:  2015-05-26

3.  A Family-Centered Model for Sharing Genetic Risk.

Authors:  Mary B Daly
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

4.  Return of individual research results from genomic research: A systematic review of stakeholder perspectives.

Authors:  Danya F Vears; Joel T Minion; Stephanie J Roberts; James Cummings; Mavis Machirori; Mwenza Blell; Isabelle Budin-Ljøsne; Lorraine Cowley; Stephanie O M Dyke; Clara Gaff; Robert Green; Alison Hall; Amber L Johns; Bartha M Knoppers; Stephanie Mulrine; Christine Patch; Eva Winkler; Madeleine J Murtagh
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

5.  Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.

Authors:  Amanda M Willis; Sian K Smith; Bettina Meiser; Mandy L Ballinger; David M Thomas; Martin Tattersall; Mary-Anne Young
Journal:  J Genet Couns       Date:  2018-02-17       Impact factor: 2.537

6.  Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS).

Authors:  Ashley Crook; Loren Plunkett; Laura E Forrest; Nina Hallowell; Samantha Wake; Kathryn Alsop; Margaret Gleeson; David Bowtell; Gillian Mitchell; Mary-Anne Young
Journal:  Eur J Hum Genet       Date:  2014-05-14       Impact factor: 4.246

7.  Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences.

Authors:  Deborah R Gordon; Carmen Radecki Breitkopf; Marguerite Robinson; Wesley O Petersen; Jason S Egginton; Kari G Chaffee; Gloria M Petersen; Susan M Wolf; Barbara A Koenig
Journal:  AJOB Empir Bioeth       Date:  2018-12-31

8.  "I would like to discuss it further with an expert": a focus group study of Finnish adults' perspectives on genetic secondary findings.

Authors:  M Vornanen; K Aktan-Collan; N Hallowell; H Konttinen; H Kääriäinen; A Haukkala
Journal:  J Community Genet       Date:  2018-01-16

Review 9.  Informed Consent in the Genomics Era.

Authors:  Shannon Rego; Megan E Grove; Mildred K Cho; Kelly E Ormond
Journal:  Cold Spring Harb Perspect Med       Date:  2020-08-03       Impact factor: 5.159

10.  TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.

Authors:  Rachel Delahunty; Linh Nguyen; Stuart Craig; Belinda Creighton; Dinuka Ariyaratne; Dale W Garsed; Elizabeth Christie; Sian Fereday; Lesley Andrews; Alexandra Lewis; Sharne Limb; Ahwan Pandey; Joy Hendley; Nadia Traficante; Natalia Carvajal; Amanda B Spurdle; Bryony Thompson; Michael T Parsons; Victoria Beshay; Mila Volcheck; Timothy Semple; Richard Lupat; Kenneth Doig; Jiaan Yu; Xiao Qing Chen; Anna Marsh; Christopher Love; Sanela Bilic; Maria Beilin; Cassandra B Nichols; Christina Greer; Yeh Chen Lee; Susan Gerty; Lynette Gill; Emma Newton; Julie Howard; Rachel Williams; Christie Norris; Andrew N Stephens; Erin Tutty; Courtney Smyth; Shona O'Connell; Thomas Jobling; Colin J R Stewart; Adeline Tan; Stephen B Fox; Nicholas Pachter; Jason Li; Jason Ellul; Gisela Mir Arnau; Mary-Anne Young; Louisa Gordon; Laura Forrest; Marion Harris; Karen Livingstone; Jane Hill; Georgia Chenevix-Trench; Paul A Cohen; Penelope M Webb; Michael Friedlander; Paul James; David Bowtell; Kathryn Alsop
Journal:  J Clin Oncol       Date:  2022-03-09       Impact factor: 50.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.